Eczema Treatment Trial Hits a Snag
Johnson & Johnson made a tough call recently. They stopped a mid-stage trial for a new eczema drug. The drug, JNJ-5939, was supposed to help people with moderate to severe eczema. But it didn't work as well as hoped. The trial showed that the drug was safe to use. People didn't have bad reactions t